3-25597903-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_000965.5(RARB):c.*1287T>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.208 in 153,250 control chromosomes in the GnomAD database, including 5,297 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.21 ( 5284 hom., cov: 32)
Exomes 𝑓: 0.11 ( 13 hom. )
Consequence
RARB
NM_000965.5 3_prime_UTR
NM_000965.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 7.06
Publications
12 publications found
Genes affected
RARB (HGNC:9865): (retinoic acid receptor beta) This gene encodes retinoic acid receptor beta, a member of the thyroid-steroid hormone receptor superfamily of nuclear transcriptional regulators. This receptor localizes to the cytoplasm and to subnuclear compartments. It binds retinoic acid, the biologically active form of vitamin A which mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation. It is thought that this protein limits growth of many cell types by regulating gene expression. The gene was first identified in a hepatocellular carcinoma where it flanks a hepatitis B virus integration site. Alternate promoter usage and differential splicing result in multiple transcript variants. [provided by RefSeq, Mar 2014]
TOP2B (HGNC:11990): (DNA topoisomerase II beta) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
TOP2B Gene-Disease associations (from GenCC):
- B-cell immunodeficiency, distal limb anomalies, and urogenital malformationsInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, ClinGen
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.208 AC: 31652AN: 151922Hom.: 5270 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
31652
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.107 AC: 129AN: 1208Hom.: 13 Cov.: 0 AF XY: 0.0997 AC XY: 61AN XY: 612 show subpopulations
GnomAD4 exome
AF:
AC:
129
AN:
1208
Hom.:
Cov.:
0
AF XY:
AC XY:
61
AN XY:
612
show subpopulations
African (AFR)
AF:
AC:
16
AN:
34
American (AMR)
AF:
AC:
5
AN:
26
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
44
East Asian (EAS)
AF:
AC:
1
AN:
26
South Asian (SAS)
AF:
AC:
0
AN:
12
European-Finnish (FIN)
AF:
AC:
54
AN:
458
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
40
AN:
552
Other (OTH)
AF:
AC:
8
AN:
56
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.209 AC: 31708AN: 152042Hom.: 5284 Cov.: 32 AF XY: 0.205 AC XY: 15247AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
31708
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
15247
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
19393
AN:
41394
American (AMR)
AF:
AC:
2560
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
432
AN:
3472
East Asian (EAS)
AF:
AC:
604
AN:
5184
South Asian (SAS)
AF:
AC:
654
AN:
4820
European-Finnish (FIN)
AF:
AC:
1050
AN:
10598
Middle Eastern (MID)
AF:
AC:
37
AN:
292
European-Non Finnish (NFE)
AF:
AC:
6515
AN:
67990
Other (OTH)
AF:
AC:
369
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1066
2132
3198
4264
5330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
533
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.